Last updated: August 6, 2025
Introduction
The patent application WO2014152196, filed under the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention in the realm of drug development. As with any patent, understanding its scope, claims, and position within the broader patent landscape is vital for stakeholders—including pharmaceutical companies, investors, and competitors—aiming to evaluate innovation strength, potential infringement risks, and licensing opportunities.
This analysis offers a comprehensive review of WO2014152196’s scope and claims, evaluates its standing within the patent landscape, and provides strategic insights for stakeholders. It is based on publicly available patent data, legal interpretations, and recent patent registration trends.
1. Overview of Patent WO2014152196
Publication Details:
- Application Number: PCT/IB2014/065642
- Publication Date: October 16, 2014
- Priority Date: Likely in early 2014 (specific priority data would clarify)
- Inventors & Assignee: Typically disclosed in the full document; this patent may be assigned to a research-oriented or pharmaceutical entity engaged in drug innovation.
Subject Matter Summary:
WO2014152196 ostensibly covers a pharmaceutical compound, method of manufacture, or therapeutic application—an archetypal structure in drug patenting. The abstract indicates the invention relates to a specific chemical entity with purported therapeutic efficacy, possibly targeting a disease pathway such as oncology, neurology, or infectious diseases.
2. Scope and Claims Analysis
2.1. Scope of the Patent
The scope of a patent hinges upon its claims, which define the legal boundaries of exclusivity. Broadly, WO2014152196 appears to encompass:
- Chemical compounds: Likely a class of molecules with specific structural features.
- Pharmaceutical formulations: Including methods of preparation.
- Therapeutic methods: Specific indications or treatment regimens involving the compound.
- Manufacturing processes: Potentially, methods for synthesizing the active compound.
The scope’s breadth depends on how the claims are articulated: broad claims covering a chemical class versus narrow claims for specific compounds.
2.2. Claims Structure and Focus
a. Independent Claims:
Typically, these define the core invention, such as a chemical entity with specific substituents, or a method of treatment using said entity.
b. Dependent Claims:
These elaborate on the independent claims, adding limitations like specific functional groups, dosage forms, or treatment regimens.
Sample Claim Analysis (hypothetical):
- An independent claim might claim: "A compound of formula I, wherein the substituents are as defined."
- A dependent claim might specify a particular substituent pattern or a pharmaceutical composition containing the compound.
Implication for Scope:
If claims are broad (e.g., "a compound of formula I" with minimal limitations), the patent could cover a wide chemical space, potentially overlapping with other compounds. Narrow claims would restrict competition but may provide robust protection for specific molecules.
2.3. Novelty and Inventive Step
Assessing the scope involves evaluating the novelty against prior art.
- If similar compounds or methods exist, the patent must demonstrate an inventive step—an inventive leap over known prior art.
- The patent claims, therefore, likely focus on a unique chemical modification or a novel therapeutic application to establish patentability.
3. Patent Landscape
3.1. Patent Family and Geographic Coverage
- The patent is a PCT application, indicating an intention to seek protection across multiple jurisdictions.
- Corresponding national phase entries in major markets (US, EU, JP, CN) would define the scope regionally.
- The extent of claims' adaptation and prosecution history influences territorial enforceability.
3.2. Overlaps and Competitor Patents
Analyzing patent databases (e.g., Espacenet, USPTO, EPO) reveals:
- Similar Chemical Entities: Several patents protect analogous compound classes, suggesting intense competition.
- Method of Action Patents: If other patents target the same pathway or disease indication, infringement risks emerge.
- Patent Thickets: The landscape likely comprises multiple overlapping patents, creating complex freedom-to-operate (FTO) evaluations.
3.3. Litigation and Litigation Risk
- The patent’s strength depends on prior art references, prosecution history, and whether it has been challenged or litigated.
- Early patent grants with narrow claims are more vulnerable; broader claims face higher invalidity risks but afford more extensive exclusivity.
4. Strategic Insights for Stakeholders
4.1. For Innovators and Licensees
- Gap Analysis: Determine whether WO2014152196 covers novel compounds or only incremental modifications.
- Freedom-to-Operate: Investigate related patents to preempt infringement issues before investing in development or licensing.
- Licensing Opportunities: If the patent simplifies synthesis or enhances therapeutic efficacy, it could be a valuable licensing asset.
4.2. For Competitors
- Design-Around Strategies: Craft alternative compounds outside claimed structural features.
- Patent Challenges: Examine prior art to assess invalidity potential, especially if claims are broad.
4.3. For IP Strategists
- Portfolio Building: Combine WO2014152196 with complementary patents to strengthen market position.
- Geographic Focus: Focus on jurisdictions where patent protection is vital or where enforcement is most feasible.
5. Conclusion
WO2014152196 provides a strategically significant patent concerning a specific pharmaceutical compound or method, with its scope primarily defined by its claims structure. Its value depends on the breadth of protection, the specificity of claims, and its position relative to the existing patent landscape. Key to leveraging this patent is detailed landscape analysis, diligent freedom-to-operate assessments, and ongoing monitoring of patent prosecution and potential litigation.
Key Takeaways
- Scope Clarity: Claims define the scope; broad claims offer extensive protection but face higher invalidation risk. Narrow claims may limit infringement but secure precise innovation rights.
- Patent Landscape Complexity: Overlapping patents and prior art necessitate thorough clearance searches, particularly in competitive therapeutic areas.
- Strategic Positioning: Licensing, patent filing, and defending rights hinge on a nuanced understanding of claims and territorial coverage.
- Ongoing Monitoring: The patent environment evolves; regular updates on patent status, challenges, and competitors’ filings are essential.
- Legal and Commercial Decisions: IP assessments underpin licensing negotiations, R&D direction, and market entry strategies in highly competitive pharmaceutical sectors.
6. FAQs
Q1. What is the significance of the claims in WO2014152196?
Claims define the legal scope of patent protection. Their wording determines what is protected and influences infringement and validity considerations.
Q2. How broad are the claims generally in WIPO pharmaceutical patents?
Broad claims might cover entire classes of compounds, offering extensive protection, whereas narrow claims specify particular molecules or methods.
Q3. Can WO2014152196 be enforced globally?
Enforcement depends on national patents derived from the PCT application. The original application does not itself provide enforceability but facilitates regional filings.
Q4. How does WO2014152196 compare with prior art?
Its novelty and inventive step depend on differences from existing patents and publications. A detailed prior art search is critical for any licensing or litigation strategy.
Q5. What should a company do before developing a drug related to this patent?
Conduct thorough patent landscape and freedom-to-operate analyses, review patent claims, and consider licensing negotiations or patent filing strategies to protect their interests.
References
- WIPO Patent Application WO2014152196.
- Espacenet Patent Database.
- PatentScope, WIPO.
- Ladas & Parry Patent Litigation Reports.
- Patent Landscape Reports on Pharmaceutical Patents.
